Concepedia

Harri Visapää

HV

Statistics

Publications

16

Citations

724

H-Index

12

Active since

2002

Affiliations

Helsinki University Hospital(Current)

University of Helsinki

University of California, Los Angeles

Harri Visapää is an author at Helsinki University Hospital specializing in medicine, urology, and oncology.

ORCID

Top concepts

Publications per year

2002–2018

16

Publications

16

PROGNOSTIC VALUE OF CARBONIC ANHYDRASE IX AND KI67 AS PREDICTORS OF SURVIVAL FOR RENAL CLEAR CELL CARCINOMA

Matthew Bui, Harri Visapää, David B. Seligson et al. · The Journal of Urology · 2004 · 194 citations

Correlation of Ki-67 and gelsolin expression to clinical outcome in renal clear cell carcinoma

Harri Visapää, Matthew Bui, Yunda Huang et al. · Urology · 2003 · 107 citations

, , +8

Tissue microarray analysis of cytoskeletal actin‐associated biomarkers gelsolin and E‐cadherin in urothelial carcinoma

Jianyu Rao, David B. Seligson, Harri Visapää et al. · Cancer · 2002 · 90 citations · Full text

Adaptive radiotherapy in muscle invasive urinary bladder cancer – An effective method to reduce the irradiated bowel volume

Laura Tuomikoski, Juhani Collan, Jani Keyriläinen et al. · Radiotherapy and Oncology · 2011 · 81 citations

, , +7

MRI-only based radiation therapy of prostate cancer: workflow and early clinical experience

Mikko Tenhunen, Juha Korhonen, Mika Kapanen et al. · Acta Oncologica · 2018 · 67 citations · Full text

1–5 of 16